Chemoinformaics analysis of Quinazoline Alkaloid vasicine
| Molecular Weight | 188.23 | nRot | 0 |
| Heavy Atom Molecular Weight | 176.134 | nRig | 16 |
| Exact Molecular Weight | 188.095 | nRing | 3 |
| Solubility: LogS | -1.273 | nHRing | 2 |
| Solubility: LogP | 1.162 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 29.3735 |
| nHD | 1 | BPOL | 14.8885 |
| QED | 0.664 |
| Synth | 3.097 |
| Natural Product Likeliness | -0.104 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.011 |
| HIA | 0.017 |
| CACO-2 | -4.64 |
| MDCK | 0.0000228 |
| BBB | 0.992 |
| PPB | 0.29124 |
| VDSS | 4.736 |
| FU | 0.624137 |
| CYP1A2-inh | 0.255 |
| CYP1A2-sub | 0.112 |
| CYP2c19-inh | 0.218 |
| CYP2c19-sub | 0.482 |
| CYP2c9-inh | 0.027 |
| CYP2c9-sub | 0.245 |
| CYP2d6-inh | 0.152 |
| CYP2d6-sub | 0.881 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.191 |
| CL | 11.272 |
| T12 | 0.873 |
| hERG | 0.028 |
| Ames | 0.09 |
| ROA | 0.846 |
| SkinSen | 0.268 |
| Carcinogencity | 0.756 |
| EI | 0.067 |
| Respiratory | 0.336 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.692498 |